About SAGE Therapeutics
SAGE Therapeutics is a company based in Boston (United States) founded in 1971 by Vincent Foglia was acquired by Supernus Pharmaceuticals in June 2025.. SAGE Therapeutics has raised $105.8 million across 6 funding rounds from investors including Bank of America, Supernus Pharmaceuticals and Orbimed. The company has 487 employees as of February 29, 2024. SAGE Therapeutics operates in a competitive market with competitors including Boston Scientific, Medtronic, Jazz Pharmaceuticals, GE Healthcare and Johnson & Johnson, among others.
- Headquarter Boston, United States
- Employees 487 as on 29 Feb, 2024
- Founders Vincent Foglia
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$105.8 M (USD)
in 6 rounds
-
Latest Funding Round
$649.99 M (USD), Post-IPO
Jan 15, 2021
-
Investors
Bank of America
& 6 more
-
Employee Count
487
as on Feb 29, 2024
-
Acquired by
Supernus Pharmaceuticals
(Jun 16, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Leadership Team
35 people
Data Analysis and Operations Team
10 people
Software Development Team
8 people
Legal and Compliance
6 people
Human Resources and Administration
6 people
Operations Team
5 people
Senior Team
4 people
Product Management Team
3 people
Unlock access to complete
Funding Insights of SAGE Therapeutics
SAGE Therapeutics has successfully raised a total of $105.8M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $649.99 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $650.0M
-
First Round
First Round
(01 Sep 2011)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Post-IPO - SAGE Therapeutics | Valuation |
investors |
|
| Mar, 2014 | Amount | Series C - SAGE Therapeutics | Valuation | Orbimed , Foresite Capital | |
| Jan, 2014 | Amount | Series C - SAGE Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in SAGE Therapeutics
SAGE Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Bank of America, Supernus Pharmaceuticals and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided to early-stage life science companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by SAGE Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - SAGE Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sage Therapeutics Comparisons
Competitors of SAGE Therapeutics
SAGE Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Boston Scientific, Medtronic, Jazz Pharmaceuticals, GE Healthcare and Johnson & Johnson, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Wide range of medical devices
|
|
| domain | founded_year | HQ Location |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Materials management solutions are provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Healthcare solutions are provided by Johnson & Johnson globally.
|
|
| domain | founded_year | HQ Location |
Diagnostic and surgical products for women's healthcare are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sage Therapeutics
Frequently Asked Questions about SAGE Therapeutics
When was SAGE Therapeutics founded?
SAGE Therapeutics was founded in 1971 and raised its 1st funding round 40 years after it was founded.
Where is SAGE Therapeutics located?
SAGE Therapeutics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of SAGE Therapeutics?
Vincent Foglia is the current CEO of SAGE Therapeutics. They have also founded this company.
Is SAGE Therapeutics a funded company?
SAGE Therapeutics is a funded company, having raised a total of $105.8M across 6 funding rounds to date. The company's 1st funding round was a Series C of $10M, raised on Sep 01, 2011.
How many employees does SAGE Therapeutics have?
As of Feb 29, 2024, the latest employee count at SAGE Therapeutics is 487.
What does SAGE Therapeutics do?
SAGE Therapeutics was founded in 1971 in Boston, United States, and focuses on the biotechnology sector. Drug candidates targeting GABAA and NMDA receptors are developed for rare central nervous system disorders, including those related to mood, seizure, cognition, anxiety, sleep, pain, epilepsy, and movement. A pipeline of products is maintained, with the lead candidate SAGE-547 intended for postpartum depression treatment. Operations emphasize therapeutic innovation in neurology.
Who are the top competitors of SAGE Therapeutics?
SAGE Therapeutics's top competitors include Jazz Pharmaceuticals, GE Healthcare and Medtronic.
Who are SAGE Therapeutics's investors?
SAGE Therapeutics has 7 investors. Key investors include Bank of America, Supernus Pharmaceuticals, Orbimed, Arch Venture Partners, and Foresite Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.